DCF — COOPERMAN BARNABAS MEDICAL CENTER
Enterprise Value: $-844.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-844.0M
Enterprise Value
$-286.4M
PV of Cash Flows
$-557.6M
PV of Terminal Value
$-898.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.1B | $-42.0M | -4.0% | $-88.7M | $-80.7M |
| Year 2 | $1.1B | $-31.9M | -3.0% | $-80.0M | $-66.1M |
| Year 3 | $1.2B | $-21.2M | -2.0% | $-70.7M | $-53.1M |
| Year 4 | $1.2B | $-15.8M | -1.0% | $-66.8M | $-45.6M |
| Year 5 | $1.2B | $-13.1M | -1.0% | $-65.7M | $-40.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-844.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.1B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04306049544761888
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5